Skip to main content
Premium Trial:

Request an Annual Quote

Real Time Genomics Snares $5M Investment

NEW YORK (GenomeWeb News) – Real Time Genomics today announced a $5 million investment for the expansion of its commercial operations.

Steve Lombardi, CEO of Real Time Genomics, declined to identify who the investor is. The San Bruno, Calif.-based genomics analytics firm said that it comprises cash and the conversion of debt. The funding will be used for sales and marketing and for genomics applications development.

Steve Lombardi, CEO of Real Time Genomics, called the financing an "evolutionary milestone for the company where we begin to establish a strong commercial presence in the market."

The company introduced its platform in February. The first version called RTG Family Caller simultaneously analyzes genomic data from related individuals "within a patented Bayesian algorithmic framework" to identify all classes of variants. The system is designed to be compatible with sequencers from providers including Illumina, Life Technologies' Ion Torrent, and Roche's 454 Life Sciences.

In the past month, Real Time Genomics has forged deals with Knome, the J. Craig Venter Institute, and Omicia.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.